Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Abbvie Inc patents

Recent patent applications related to Abbvie Inc. Abbvie Inc is listed as an Agent/Assignee. Note: Abbvie Inc may have other listings under different names/spellings. We're not affiliated with Abbvie Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Abbvie Inc-related inventors




Date Abbvie Inc patents (updated weekly) - BOOKMARK this page
07/13/17N-(4-phenyl)-n'-(3-fluorophenyl)urea docusate
07/13/17Methods to control protein heterogeneity
07/06/17Solid dosage forms
07/06/17Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor
07/06/17Syringe with two-stage sealing pressure
07/06/17Atrasentan mandelate salts
06/29/17Formulations of pyrimidinedione derivative compounds
06/29/17Antibody drug conjugates with cell permeable bcl-xl inhibitors
06/29/17Wearable automatic injection device and related methods of use
06/22/17Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers
06/22/17Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
06/22/17Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
06/22/17Self-injection tool with movable needle shroud
06/22/17Primary carboxamides as btk inhibitors
06/22/17Substituted indoles
06/15/17Antibodies against the rgm a protein and uses thereof
06/08/17Systems and methods for tubing delivery
06/08/17Anti-viral compounds
06/08/17Anti-viral compounds
06/08/17High purity oritavancin and producing same
06/08/17Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
06/08/17Hexahydrodiazepinoquinolines carrying a cyclic radical
06/08/17Isolation and purification of antibodies using protein a affinity chromatography
06/08/17Low acidic species compositions and methods for producing and using the same
06/01/17Methods for treating hcv
06/01/17Anti-hulrrc15 antibody drug conjugates and methods for their use
06/01/17Anti-hulrrc15 antibody drug conjugates and methods for their use
05/25/17Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
05/18/17Nampt inhibitors
05/18/17Methods to control protein heterogeneity
05/18/17Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
05/11/17Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-alpha]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
05/11/17Cell culture improvements
05/04/17Modulated lysine variant species compositions and methods for producing and using the same
04/27/17Heterocyclic kinase inhibitors
04/20/17Medication packaging and dispensing system
04/06/17Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
04/06/17Dual specific binding proteins having a receptor sequence
03/30/17Single-chain multivalent binding protein compositions and methods
03/16/17Anti-egfr antibodies and antibody drug conjugates
03/16/17Salt and crystalline forms thereof of a drug
03/16/17Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use
03/16/17Methods for treating relapsing forms of multiple sclerosis
03/09/17Nampt inhibitors
03/09/17Crystalline bromodomain inhibitors
03/02/17Methods of administering elagolix
03/02/17Fused heterocyclic compounds as s1p modulators
03/02/17Anti-viral compounds
03/02/17Il-1 binding proteins
02/23/17Methods for controlling the galactosylation profile of recombinantly-expressed proteins
02/09/17Guanidine compounds and use thereof as binding partners for 5-ht5 receptors
02/02/17Human antibodies that bind human tnf-alpha and methods of preparing the same
01/26/17Anti-aß globulomer 4d10 antibodies
01/26/17Prolactin receptor binding proteins and uses thereof
01/19/17Formulations of nonopioid and confined opioid analgesics
01/19/17Bromodomain inhibitors
01/19/17Binding proteins against vegf, pdgf, and/or their receptors
01/19/17Treatment of multidrug-resistant nephrotic syndrome (mdr-ns) in children
01/12/17Veliparib in combination with carboplatin for the treatment of triple negative breast cancer
01/12/17Acoustic mixing for auto granulation
01/12/17Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases
01/12/17Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
01/05/17Oxindole derivatives carrying an amine-substituted piperidyl-azetidinyl substituent and use thereof for treating vasopressine-related diseases
01/05/17Antibodies to receptor of advanced glycation end products (rage) and uses thereof
12/29/16Solid pharmaceutical compositions for treating hcv
Patent Packs
12/29/16Solid pharmaceutical compositions for treating hcv
12/29/166 phenyl or 6 pyridin 3 yl indazole derivatives and methods of use
12/22/16Medicine container, assembling the container, and dispensing the medicine from the container
12/22/16Antiviral compounds and uses thereof
12/15/16Nuclear receptor modulators
12/15/16Carbidopa and l-dopa prodrugs and methods of use
12/08/166-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and use
12/08/16Hepatitis c inhibitors and uses thereof
12/01/16Anti-cd40 antibodies and uses thereof
11/24/16Bcl-xl inhibitory compounds having low cell permeability and antibody drug conjugates including the same
11/24/16Spiro-cyclic amine derivatives as s1p modulators
11/24/16Raman spectroscopy for bioprocess operations
11/17/16Bromodomain inhibitors
11/17/16Process for preparing antiviral compounds
11/17/16Methods for treating hcv
Patent Packs
11/10/16Combination therapy with parp inhibitors
11/10/16Novel tricyclic compounds
11/10/16Abeta conformer selective anti-abeta globulomer monoclonal antibodies
11/10/16Composition and the diagnosis and treatment of diseases associated with neurite degeneration
11/03/16Methods for treating hcv
11/03/16Methods for treating hcv
11/03/16Methods for treating hcv
11/03/16Novel inhibitor compounds of phosphodiesterase type 10a
11/03/16Glycoengineered binding protein compositions
11/03/16Dual variable domain immunoglobulins and uses thereof
10/20/16Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/20/16Indazolones as modulators of tnf signaling
10/20/16Tricyclic modulators of tnf signaling
10/20/16Indazolones as modulators of tnf signaling
10/20/16Substituted pyrazolopyrimidines and use
10/06/16Sustained release monoeximic formulations of opioid and nonopioid analgesics
10/06/16Systems and methods for generating longitudinal data profiles from multiple data sources
09/29/16Dual variable domain immunoglobulins and uses thereof
09/22/16Bromodomain inhibitors
09/22/16Isolation and purification of dvd-igs
09/22/16Isolation and purification of antibodies
09/22/16Tnf-alpha binding proteins
09/15/16Phosphine ligands for catalytic reactions
09/15/16(indazol-4-yl) hexahydropyrrolopyrrolones and methods of use
09/15/16Integrated approach to the isolation and purification of antibodies
09/01/16Stabilized pharmaceutical dosage forms comprising atrasentan
09/01/16Protein purification methods to reduce acidic species
08/25/16Compositions and methods for treating psoriatic arthritis
08/18/16Spirocyclic hat inhibitors and methods for their use
08/18/16Methods of treatment using selective bcl-2 inhibitors
Social Network Patent Pack
08/18/16Dihydro-pyrrolopyridinone inhibitors
08/18/16Crystalline bromodomain inhibitors
08/18/16Modulated lysine variant species compositions and methods for producing and using the same
08/18/16Methods for treating hcv
08/11/16Stable solid units and methods of making the same
08/11/16Methods for treating hcv
08/04/16Crystal forms
08/04/16Novel tricyclic compounds
08/04/16Protein formulations and methods of making same
07/21/16Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
Patent Packs
07/21/16Methods for controlling the galactosylation profile of recombinantly-expressed proteins
07/21/16Levodopa and carbidopa intestinal gel and methods of use
07/14/16Solid antiviral dosage forms
07/14/16Tylosin a analogs and derivatives
07/14/16Lrp-8 binding proteins
07/07/16Nampt inhibitors
07/07/16Low acidic species compositions and methods for producing and using the same
06/30/16Nampt inhibitors
06/30/16Nampt inhibitors
06/30/16Devices and methods for delivering a beneficial agent to a user
06/30/16Bromodomain inhibitors
06/30/16Methods for modulating the glycosylation profile of recombinant proteins using sugars
06/30/16Cell culture improvements
06/23/16Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
06/23/16Tnf-alpha binding proteins
06/16/16Nampt inhibitors
06/09/16Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/09/16Bcl-xl inhibitory compounds and antibody drug conjugates including the same
06/09/16Monoclonal antibodies against amyloid beta protein and uses thereof
06/09/16Low mannose adalimumab compositions and uses thereof
06/02/16Synthesis of (2s,5r)-5-ethynyl-1-pyrrolidine-2-carbonitrile
06/02/16Methods for transforming yeast
06/02/16Marker to predict and monitor response to aurora kinase b inhibitor therapy
06/02/16Methods for controlling the galactosylation profile of recombinantly-expressed proteins
05/26/16Bromodomain inhibitors
05/26/16Process for preparing bicyclic amine derivatives
05/26/16Cell culture methods to reduce acidic species
05/26/16Neutralizing monoclonal antibodies against the nogo-66 receptor (ngr) and uses thereof
05/19/16Method for producing monolithic tablets
05/19/16Extended release hydrocodone acetaminophen and related methods and uses thereof
Patent Packs
05/19/16Novel inhibitor compounds of phosphodiesterase type 10a
05/19/16Methods to control protein heterogeneity
05/12/16Methods of treating ckd using predictors of fluid retention
05/12/16Mercaptoamidine derivatives and methods of use
05/12/16Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
05/05/16Substituted chromanes and use
05/05/16Substituted tetrahydropyrans and use
05/05/16Anti-dll4/vegf dual variable domain immunoglobulin and uses thereof
04/28/16Methods of reducing methylglyoxal (mgo) modification of recombinant proteins in cell culture
04/28/16Novel purification of antibodies using hydrophobic interaction chromatography
04/21/16Carbidopa and l-dopa prodrugs and methods of use
04/21/16Formulations of phenyl uracil compounds
04/21/16Wearable automatic injection system and apparatus
04/14/16Method of treating arthritis
04/07/16Modulators of 5-ht receptors and methods of use thereof
03/31/16Treatment of osteoarthritis pain
03/31/16Solid forms of anti-viral compounds
03/24/16Devices and methods for delivering a beneficial agent to a user
03/24/16Salts and crystalline forms of an apoptosis-inducing agent
03/24/16Isolation and purification of antibodies using protein a affinity chromatography
Social Network Patent Pack
03/17/16Methods for improving lipid profiles using atrasentan
03/17/16Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers
03/17/16Method of treating hcv
03/17/164,5- dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
03/17/16Indazole ureas and use
03/17/16Methods for improving lipid profiles using atrasentan
03/10/16Thiazoles and uses thereof
03/03/16Radiolabeled pde10a ligands
03/03/16Process for preparing antiviral compound
03/03/16Pyrrolo [2,3-b] pyridine cdk9 kinase inhibitors
03/03/16Therapeutic dll4 binding proteins
02/25/16Benzodiazepine and pyridodiazepine derivatives
02/18/16Methods to modulate lysine variant distribution
02/18/16Dual variable domain immunoglobulins and uses thereof
02/11/16Tetracyclic bromodomain inhibitors
02/11/16Methods for modulating the glycosylation profile of recombinant proteins using dissolved oxygen
02/11/16Cell culture methods to reduce acidic species
02/11/16Cell culture improvements
02/04/16Smyd2 inhibitors
02/04/16Nampt and rock inhibitors
Social Network Patent Pack
02/04/16Therapeutic dll4 binding proteins
02/04/16Blood-brain-barrier dual variable domain immunoglobulins and uses thereof
01/28/16Pharmaceutical compositions and their methods of use
01/14/16Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
01/07/16Biomarkers for inflammatory disease and methods of using same
01/07/16Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases
01/07/16Hepatitis c inhibitors and uses thereof
01/07/16Novel inhibitor compounds of phosphodiesterase type 10a
01/07/16Compositions and methods for treating rheumatoid arthritis
01/07/16Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
12/24/15Amyloid-beta binding proteins
12/17/15Phosphine ligands for catalytic reactions
12/10/15Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions
12/10/15Indole and indoline derivatives and methods of use thereof
12/10/15Crystal forms
12/03/15Viral inactivation during purification of antibodies
12/03/15Dual specific binding proteins directed against il-13 and/or il-17
12/03/15Dual specific binding proteins directed against il-1 and/or il-17
11/26/15Single-chain trail-receptor agonist proteins
11/26/15Anti-egfr antibodies and antibody drug conjugates
11/19/15Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
11/19/15Protein purification using displacement chromatography
11/12/15Cyanoguanidines and uses thereof
11/12/15Crystal forms
11/12/15Crystalline polymorphs
11/05/15Neuronal nicotinic agonists and methods of use
11/05/15Automatic injection device
11/05/15Dual variable domain immunoglobulins and uses thereof
10/29/15Antibodies to receptor for advanced glycation end products (rage) and uses thereof
10/22/15Isoxazolines as therapeutic agents
Social Network Patent Pack
10/22/15Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/22/15Purification of proteins using hydrophobic interaction chromatography
10/15/15Application security framework
10/15/15Compositions and methods for treating rheumatoid arthritis
10/08/15Methods for treating hcv
10/08/15Methods for treating hcv
10/08/15Methods for treating hcv
10/08/157-substituted indole mcl-1 inhibitors
10/08/15Fused heterocyclic derivatives as s1p modulators
10/01/15Inhibitors of histone methyltransferase g9a
09/24/15Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/24/15Crystalline form of a drug
09/24/15Immunobinders directed against sclerostin
09/17/15Solid antiviral dosage forms
09/17/15Tylosin a analogs and derivatives
09/17/15Low acidic species compositions and methods for producing and using the same
09/10/15Carboxamide compounds and their use as calpain inhibitors v
09/10/15Processes for the preparation of an apoptosis-inducing agent
09/10/15Characterization and/or detection of structural characteristics associated with syringes and/or automatic injection devices based on acoustics
09/03/15Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
08/27/15Novel monohydrate of azaadamantane derivatives
08/20/15Novel compounds as cannabinoid receptor ligands and uses thereof
08/20/15Dual variable domain immunoglobulins and uses thereof
08/13/15Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
08/13/15Agents for treating pain and uses thereof
08/13/15Systems and methods for detection of particles in a beneficial agent
08/06/156-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and use
08/06/15Tetracyclic cdk9 kinase inhibitors
08/06/15Anti-viral compounds







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Abbvie Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Abbvie Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';